Risk of Infection, Death From MRSA Persists in Long-Term Carriers

People who harbor methicillin-resistant Staphylococcus aureus (MRSA) for more than 1 year remain at substantial risk of MRSA-related illness or death, according to a single-center retrospective cohort study published in the July 15 issue of Clinical Infectious Diseases.

Multidisciplinary Collaboration Needed to Incorporate Genomics Into Clinical Care

Multidisciplinary collaboration is needed to incorporate genomics into clinical care, according to scientists who have launched a new initiative to investigate potential uses of genetic testing in primary care. Their commentary on the topic, published in the July 29 issue of Nature Genetics, addresses the gap between research on gene–disease associations and the use of […]

Longer SIDS Risk for Premature Babies

Premature babies may be at risk for SIDS (sudden infant death syndrome) longer than full-term babies, a new study shows. SIDS is the sudden, unexpected death of a baby less than 1 year old with no explanation from a thorough investigation.

Head Covering May Increase SIDS Risk

Babies who die from sudden infant death syndrome (SIDS) are often found with their heads covered by bedding, and now new research suggests that this covering usually precedes death and may, in fact, be causally related.

Growth Hormone Therapy May Decrease Diabetes Risk in Girls With Turner Syndrome

Growth hormone (GH) treatment has beneficial effects on body composition, regional fat deposition and glucose tolerance in girls with Turner syndrome, a study suggests. "We found that GH-treated girls were leaner, with less abdominal fat and normal glucose tolerance compared with never-treated girls in the current study and compared with Turner syndrome girls in studies […]

Effective Treatment of Pancreatic Cancer Remains Elusive

Although therapeutic strategies have advanced for many common gastrointestinal cancers, significant progress in the treatment of pancreatic cancer remains elusive. The eagerly anticipated results of randomized trials that evaluated gemcitabine-based combination regimens have proven to be disappointing, researchers report in a review paper that discusses the use of systemic therapy in advanced pancreatic cancer. Whereas […]